Clinical Trials Directory

Trials / Completed

CompletedNCT03713762

Peribulbar Block: Lidocaine-bupivacaine vs Lidocaine-bupivacaine-fentanyl

Anesthesia With Peribulbar Block: Lidocaine-bupivacaine vs Lidocaine-bupivacaine-fentanyl

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Centro Medico Docente la Trinidad · Academic / Other
Sex
All
Age
45 Years – 90 Years
Healthy volunteers
Accepted

Summary

Ophthalmological procedures such as cataract extraction can be carried out with a peribulbar block (PBB). The advantages of this anesthetic technique include a lower incidence of coughing, unwanted movements and emesis during awakening, in addition to providing adequate postoperative analgesia. The researchers want to investigate whether the use of fentanyl citrate by peribulbar route, when administered with a local anesthetic, shortens the anesthetic latency, interfere with the degree of akinesia and if provides greater postoperative analgesia.

Detailed description

Article Type. Clinical trial study

Conditions

Interventions

TypeNameDescription
DRUGperibulbar block 1 lidocaine/bupivacainePeribulbar block: 100 mg of lidocaine 5% and 15 mg of bupivacaine 0.5% for a total volume of the anesthetic mixture of 5 ml.
DRUGperibulbar block 2 lidocaine/bupivacaine/fentanylPeribulbar block: 100 mg of lidocaine 5%, 15 mg of 0.5% bupivacaine and 50 mcg of fentanyl citrate for a total volume of the anesthetic mixture of 6 ml.

Timeline

Start date
2009-10-01
Primary completion
2009-11-30
Completion
2009-11-30
First posted
2018-10-22
Last updated
2018-10-23

Regulatory

Source: ClinicalTrials.gov record NCT03713762. Inclusion in this directory is not an endorsement.